AA
TMO icon

AlphaMark Advisors’s Thermo Fisher Scientific TMO Stock Holding History

AlphaMark Advisors’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$1.2M Buy
2,308
+72
+3% +$39.6K 0.52% 42
2024
Q3 		$1.38M Buy
2,236
+22
+1% +$13K 0.48% 41
2024
Q2 		$1.22M Buy
2,214
+12
+0.5% +$6.88K 0.43% 40
2024
Q1 		$1.28M Sell
2,202
-102
-4% -$57.2K 0.45% 39
2023
Q4 		$1.22M Buy
2,304
+45
+2% +$21.8K 0.46% 40
2023
Q3 		$1.14M Buy
2,259
+15
+0.7% +$7.99K 0.49% 41
2023
Q2 		$1.17M Sell
2,244
-463
-17% -$250K 0.54% 42
2023
Q1 		$1.56M Buy
2,707
+91
+3% +$51.3K 0.7% 37
2022
Q4 		$1.44M Sell
2,616
-120
-4% -$63.6K 0.72% 37
2022
Q3 		$1.39M Sell
2,736
-7
-0.3% -$3.92K 0.69% 36
2022
Q2 		$1.49M Buy
2,743
+15
+0.5% +$8.26K 0.69% 37
2022
Q1 		$1.61M Sell
2,728
-225
-8% -$129K 0.6% 42
2021
Q4 		$1.97M Sell
2,953
-3
-0.1% -$1.87K 0.69% 35
2021
Q3 		$1.69M Buy
2,956
+17
+0.6% +$9.33K 0.61% 41
2021
Q2 		$1.48M Sell
2,939
-19
-0.6% -$8.96K 0.54% 46
2021
Q1 		$1.35M Sell
2,958
-649
-18% -$310K 0.52% 47
2020
Q4 		$1.68M Sell
3,607
-3,465
-49% -$1.62M 0.64% 39
2020
Q3 		$3.12M Sell
7,072
-1,816
-20% -$750K 1.29% 21
2020
Q2 		$3.22M Sell
8,888
-175
-2% -$58.7K 1.39% 24
2020
Q1 		$2.57M Sell
9,063
-237
-3% -$74.7K 1.42% 25
2019
Q4 		$3.02M Buy
9,300
+128
+1% +$38.8K 1.26% 29
2019
Q3 		$2.67M Buy
9,172
+171
+2% +$49K 1.16% 35
2019
Q2 		$2.64M Buy
9,001
+200
+2% +$55.1K 1.16% 36
2019
Q1 		$2.41M Buy
+8,801
New +$2.19M 1.02% 43

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AlphaMark Advisors's TMO Position: Q4 2024 in Review

AlphaMark Advisors increased its Thermo Fisher Scientific (TMO) stake by 3.2% in Q4 2024, buying an estimated $39.6K and bringing the position to 2,308 shares worth $1.2M. The position accounts for 0.52% of the portfolio, ranked #42.

AlphaMark Advisors first reported a position in TMO in Q1 2019 and has held it in 24 quarters since. The position peaked at $3.22M in Q2 2020. 2,617 funds tracked by Wall St. Rank hold TMO as of Q4 2024.

  • AlphaMark Advisors held 2,308 shares of Thermo Fisher Scientific worth $1.2M as of Q4 2024.
  • AlphaMark Advisors bought 72 Thermo Fisher Scientific shares in Q4 2024, an estimated $39.6K.
  • Thermo Fisher Scientific made up 0.52% of AlphaMark Advisors's portfolio in Q4 2024, its #42 holding.
  • AlphaMark Advisors first reported a position in Thermo Fisher Scientific in Q1 2019 and has held it in 24 quarters since.
  • AlphaMark Advisors's Thermo Fisher Scientific position peaked at $3.22M in Q2 2020.
  • 2,617 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2024.

Based on AlphaMark Advisors's 13F filing for Q4 2024, filed 21 Jan 2025.